Market Overview

Benzinga's Top #PreMarket Gainers


Orexigen Therapeutics, Inc. (NASDAQ: OREX) shares gained 10.62% to $8.02 in the pre-market trading session following Thursday's EC approval of Mysimba.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) gained 9.61% to $126.65 in pre-market trading on rumor of Shire interest. Deutsche Bank lifted the price target on the stock from $90 to $140.

BlackBerry Limited (NASDAQ: BBRY) shares jumped 5.81% to $9.84 in pre-market trading. BlackBerry posted a surprise profit for the fiscal fourth quarter, but the company's sales missed analysts' estimates.

The Dow Chemical Company (NYSE: DOW) shares rose 4.78% to $49.10 in pre-market trading after the company announced its plans to spin off Chlor Alkali unit to merge that unit with Olin Corp (NYSE: OLN).

Finish Line Inc. (NASDAQ: FINL) shares surged 3.38% to $24.75 in pre-market trading after the company reported better-than-expected results for the fiscal fourth quarter.

Posted-In: Premarket MoversNews Pre-Market Outlook Markets Movers


Related Articles (BMRN + BB)

View Comments and Join the Discussion!

BlackBerry Q4 Conference Call: A Play-By-Play Recap

Morgan Stanley Comments On Facebook's F8 Conference, Says 'A Lot To Be Bullish About'